Home / Biotechnology / Hematopoie

Hematopoietic Stem Cells Transplantation Market, By Transplant Type (Allogeneic Transplant, Autologous Transplant), By Application (Leukemia, Lymphoproliferative Disorders, Solid Tumors, Non-Malignant Disorders) - Growth, Share, Opportunities & Competitive Analysis, 2019 - 2027

The Hematopoietic Stem Cell Transplantation market was valued at USS 5,540 million in 2019 and expected to grow at a CAGR of 15% during the forecast period from 2020 to 2027 to reach around USD 12,072 million in 2027.

Transplantation of bone marrow, umbilical cord blood or peripheral blood derived multipotent hematopoietic stem cells is called as Hematopoietic stem cell transplantation (HSCT). Hematopoietic stem cell transplantation (HSCT) is mainly used in treatment of patients suffering from blood cancer or bone marrow. Hematopoietic stem cell transplantation (HSCT) is widely used and adopted for treatment of leukemia and multiple myeloma. Hematopoietic stem cell transplantation (HSCT) specifically used for the removal of remains of cancer cells with the aid of high doses of chemo therapy with successive stem cell rescue. The global Hematopoietic Stem Cell Transplantation market report offers the detailed market insights on Hematopoietic Stem Cell Transplantation on global regional and country level. The key regions covered in the report includes North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Major countries covered in the report are U.S., Canada, Mexico, Brazil, Argentina, China, Japan, India, South Korea, Germany, UK, France, Italy, Spain, Russia, South Africa, Turkey, Israel, GCC countries, etc. The report provides market size of Hematopoietic Stem Cell Transplantation for historical period i.e. from 2015 to 2019, estimates for the current year and forecast for the period between 2021 to 2027. The market size of Hematopoietic Stem Cell Transplantation is further breakdown on regional and country level.

Based on its type, the global Hematopoietic Stem Cell Transplantation market can be segmented into Autologous HSCT and Allogeneic HSCT. Although it accounted for major share of the HSCT industry in 2019, Autologous HSCT is a critical and intricate medical practice to be used in the treatment for various malignant and non-malignant disorders. Major factors resulted into higher adoption of autologous HSCT include access to hematopoietic progenitor cell transplant, better supportive care and accessibility of breakthrough drugs that resulted into reduced fatality among patients suffering from malignant and non-malignant blood disorders. Each of the above segment and subsegment is then further bifurcated on global, regional and country level. Market size for each segment and subsegment is given in terms of volume and value (USD Million) for historical, present and forecast years.    

Global Hematopoietic Stem Cell Transplantation Market Share by Type, 2019

Based on its Applications, the global Hematopoietic Stem Cell Transplantation market can be segmented into Leukemia, Lymphoproliferative Disorders, Solid Tumors and Non-malignant Disorders. In 2019. More than 60 thousand people in U.S. alone were diagnosed with blood cancer (Leukemia). It is estimated that currently there are more than 350 thousand active patients of leukemia in U.S.  Increasing usage of HSCT is one of the major treatments effectively increasing survival rate of patients in the region. Each of the above segment and subsegment is then further bifurcated on global, regional and country level. Market size for each segment and subsegment is given in terms of volume and value (USD Million) for historical, present and forecast years.

Global Hematopoietic Stem Cell Transplantation Market Share by Application, 2019

Apart from quantitative analysis, the global Hematopoietic Stem Cell Transplantation market report offers key trends in the industry. The report covers all key market driving forecast, restraints and opportunities for the future growth in this industry. The report helps its readers to identify the key growth pockets in global Hematopoietic Stem Cell Transplantation industry through market attractiveness analysis offered for each segment in this industry. Moreover, detailed analysis of Hematopoietic Stem Cell Transplantation industry using porter’s five forces analysis helps the buyers of this report to have birds eye view on various aspects of this industry. It details bargaining power por buyers as well as suppliers, situation of competitive rivalry, threat of substitutes and entry barriers for new entrants.

The global Hematopoietic Stem Cell Transplantation market report also covers import and export analysis on regional level. The global Hematopoietic Stem Cell Transplantation market includes most updated insights including COVID 19 impact analysis. The report covers comparative analysis of global Hematopoietic Stem Cell Transplantation market on the basis of pre and post COVID 19 scenarios.

Apart from this the report covers a dedicated section for the analysis of competition in global Hematopoietic Stem Cell Transplantation industry. The report offers detailed company market share analysis on global level which helps to understand the competitive scenario in Hematopoietic Stem Cell Transplantation industry. A detailed company profile section offers detailed insights about leading players in Hematopoietic Stem Cell Transplantation market. Company profile of each leading players includes, company overview, detailed product portfolio, financials details such as sales volume, revenue, gross margin, etc. for Escape Therapeutics, Kite Pharma Inc., PromoCell GmbH, ScienCell Research Laboratories, Thermo Fisher Scientific, Inc., CellGenixTechnologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group, Pluristem Therapeutics Inc. TiGenix N.V., Takara Bio and Stempuetics Research Pvt. Ltd. 

The global Hematopoietic Stem Cell Transplantation market report also offers insights into manufacturing cost analysis. This section focused on analysis of raw material cost, key suppliers of raw materials, labor cost, market concentration of raw materials, manufacturing cost proportion of Hematopoietic Stem Cell Transplantation, etc. Manufacturing expenses and manufacturing process of Hematopoietic Stem Cell Transplantation are key highlights of this report. In addition to this, the repot also helps to understand the marketing channels used by most of Hematopoietic Stem Cell Transplantation industry players.

Historical & Forecast Period

2015 to 2019 – Historical Years

2020 – Current year

2021 - 2027 – Forecast Period

This study report represents analysis for each segment from 2015 to 2027 considering 2019 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2020 to 2027.

Market Segmentation

Global Hematopoietic Stem Cell Transplantation Market by Type, 2015 – 2027 (USD Million)

·       Autologous HSCT

·       Allogeneic HAST

Global Hematopoietic Stem Cell Transplantation Market by Application, 2015 – 2027 (USD Million)

·       Leukemia

·       Lymphoproliferative Disorders

·       Solid Tumors

·       Non-malignant Disorders

Global Hematopoietic Stem Cell Transplantation Market by Region, 2015 - 2027

·       North America

·       Europe

·       Asia Pacific

·       Latin America

·       Middle East and Africa

Global Hematopoietic Stem Cell Transplantation Market: Key Players

·       Escape Therapeutics       

·       Kite Pharma Inc.

·       PromoCell GmbH

·       ScienCell Research Laboratories

·       Thermo Fisher Scientific, Inc.

·       CellGenixTechnologie Transfer GmbH

·       Cesca Therapeutics Inc.

·       R&D Systems

·       Genlantis

·       Lonza Group

·       Pluristem Therapeutics Inc

·       TiGenix N.V.

·       Takara Bio

·       Stempuetics Research Pvt. Ltd.

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that give a better market understanding of the overall Hematopoietic Stem Cell Transplantation market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.

Key questions answered in this report

  • COVID 19 impact analysis on global Hematopoietic Stem Cell Transplantation industry
  • What are the current market trends and dynamics in the Hematopoietic Stem Cell Transplantation market and valuable opportunities for emerging players?
  • What is driving Hematopoietic Stem Cell Transplantation market?
  • What are the key challenges to market growth?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which product type segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Hematopoietic Stem Cell Transplantation market?
  • Key growth pockets on the basis of regions, types, applications, and end-users
  • What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Choose License Type
Published Date:  Dec 2020
Category:  Biotechnology
Report ID:   57984
Report Format:   PDF
Pages:   120
Rating:    4.4 (60)
Connect With Us
+1-408-641-3282
24/7 Research Support